Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Birmingham Heartlands Hospital

     
Birmingham , B9 5SS
UK

 

Principal Investigator:
Ian Geh, MD
Contact:
James Whitehouse +44-0121-424-2187 james.whitehouse@heartofengland.nhs.uk
Activation Status of this Site:
Closed
Notes about this Site:
Birmingham Heartlands Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.